Population-level impact of isoniazid preventive therapy in South Africa

Location

Khayelitsha, South Africa, South Africa

Dates

08/01/2012 - 07/01/2015

PI

David Dowdy, MD, PhD, ScM

We are collaborating with a team that conducted a randomized trial of IPT in Khayelitsha, South Africa, to extend their findings and understand the potential population-level impact of IPT in this unique epidemiological setting.

Projects

A randomized trial of preventive therapy for...

We are evaluating the efficacy and cost-effectiveness of levofloxacin preventive therapy for pediatric contacts of MDR TB...

Read More

TB Modeling and Analysis Consortium

The TB MAC brings TB modelers together from a wide range of institutions to answer questions of global policy relevance.  I...

Read More

Assessing the social value of novel regimens...

We are collaborating with investigators from the Berman Bioethics Institute to develop novel techniques for economic evaluation...

Read More

A smoking cessation trial in HIV/AIDS...

A tobacco prevalence survey and smoking cessation trial among HIV infected patients in South Africa.

Read More

Evaluating an automated system for...

We are evaluating the accuracy and cost-effectiveness of TBDx, an automated digital microscopy system, as a screening test to...

Read More